Christopher G. Janus
Affiliations: | Neuroscience | University of Florida, Gainesville, Gainesville, FL, United States |
Area:
Aging & Memory Loss,Neurodegeneration,Dementia in Neurodegenerative Diseases, Alzheimer’s disease,Mouse Models of Neurodegenerative diseases, Learning and Memory,Spatial navigation, Behavioral plasticity, Amyloid beta, TauGoogle:
"Christopher Janus"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Moore BD, Levites Y, Xu G, et al. (2022) Soluble brain homogenates from diverse human and mouse sources preferentially seed diffuse Aβ plaque pathology when injected into newborn mouse hosts. Free Neuropathology. 3 |
| Koller EJ, De La Cruz EG, Machula T, et al. (2019) Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy. Human Molecular Genetics |
| Chakrabarty P, Li A, Ladd TB, et al. (2018) TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer's disease. The Journal of Experimental Medicine |
| Giraldo G, Brooks M, Giasson BI, et al. (2018) Locomotor differences in mice expressing wild-type human α-synuclein. Neurobiology of Aging. 65: 140-148 |
| Moore BD, Martin J, de Mena L, et al. (2017) Short Aβ peptides attenuate Aβ42 toxicity in vivo. The Journal of Experimental Medicine |
| Eskandari-Sedighi G, Daude N, Gapeshina H, et al. (2017) The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition. Molecular Neurodegeneration. 12: 72 |
| Janus C, Hernandez C, deLelys V, et al. (2016) Better Utilization of Mouse Models of Neurodegenerative Diseases in Preclinical Studies: From the Bench to the Clinic. Methods in Molecular Biology (Clifton, N.J.). 1438: 311-47 |
| Moore BD, Martin J, de Mena L, et al. (2016) P1-165: Evidence to Support γ-Secretase Modulators: Short Aβ Peptides are Protective in Vivo Alzheimer's & Dementia. 12: P466-P466 |
| Janus C, Flores AY, Xu G, et al. (2015) Behavioral abnormalities in APPSwe/PS1dE9 mouse model of AD-like pathology: comparative analysis across multiple behavioral domains. Neurobiology of Aging. 36: 2519-32 |
| Chakrabarty P, Li A, Ceballos-Diaz C, et al. (2015) IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior. Neuron. 85: 519-33 |